Company: TAK
Filing Date: 2025-06-25
Form Type: F-3ASR
Source: 0001395064-25-000097
Chunk: 3

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: F-3ASR
Chunk 3
---
 STATEMENT REGARDING FORWARD-LOOKING STATEMENTS |     |  2 |
| WHERE YOU CAN FIND MORE INFORMATION                       |     |  3 |
| DESCRIPTION OF ISSUERS                                    |     |  4 |
| OFFERING INFORMATION                                      |     |  5 |
| RISK FACTORS                                              |     |  5 |
| USE OF PROCEEDS                                           |     |  5 |
| CAPITALIZATION AND INDEBTEDNESS                           |     |  6 |
| DESCRIPTION OF SENIOR DEBT SECURITIES AND GUARANTEE       |     |  7 |
| TAXATION                                                  |     | 25 |
| PLAN OF DISTRIBUTION                                      |     | 26 |
| LEGAL MATTERS                                             |     | 28 |
| EXPERTS                                                   |     | 28 |
| ENFORCEMENT OF CIVIL LIABILITIES                          |     | 28 |

You should rely only on the information contained in or incorporated by reference into this prospectus, in any prospectus supplement or in any free writing prospectus. We have not authorized anyone to provide you with information different from that contained in or incorporated by reference in this prospectus, any prospectus supplement or any free writing prospectus. We are offering to sell the senior debt securities only in jurisdictions where offers and sales are permitted. The information contained in or incorporated by reference in this prospectus, any prospectus supplement or any free writing prospectus is accurate only as of the date on the front of those documents, regardless of the time of delivery of the documents or any sale of the senior debt securities.

<div align='center'>-i-</div>

### ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement filed with the SEC utilizing a “shelf” registration process. Under this shelf registration process, the issuers named herein may, from time to time, sell the senior debt securities described in this prospectus in one or more offerings.

This prospectus provides you with a general description of the senior debt securities that may be offered. Each time we sell senior debt securities, we will provide a prospectus supplement that will contain specific information about the terms of the senior debt securities and the offering. The prospectus supplement may also add, update or change information contained in this prospectus. The prospectus supplement will supersede this prospectus to the extent it contains information that is different from, or conflicts with, the information contained in this prospectus. You should read this prospectus, any applicable